Arcus Biosciences Inc. (RCUS)
7.72
-0.13 (-1.66%)
At close: Apr 01, 2025, 3:59 PM
Arcus Biosciences Ratios Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
PE Ratio | -4.74 | -4.6 | -5.58 | 52.95 | -12.19 | -5.83 | -7.52 | -13.63 | -23.23 |
PEG Ratio | 0.19 | -0.39 | 0.01 | -0.39 | -0.53 | -0.28 | -0.52 | -0.19 | n/a |
PS Ratio | 5.20 | 12.08 | 13.29 | 7.33 | 18.35 | 29.51 | 44.64 | 511.93 | n/a |
PB Ratio | 2.77 | 3.06 | 2.27 | 3.34 | 2.83 | 2.70 | 1.59 | 4.70 | 4.20 |
P/FCF Ratio | -7.62 | -4.28 | 3.50 | -9.94 | 13.16 | -5.87 | -7.98 | -23.66 | -24.49 |
P/OCF Ratio | -7.89 | -4.62 | 3.40 | -10.96 | 12.79 | -6.03 | -8.67 | -28.87 | -32.25 |
OCF/S Ratio | -0.66 | -2.62 | 3.91 | -0.67 | 1.43 | -4.9 | -5.15 | -17.73 | n/a |
Debt / Equity Ratio | 0.10 | 0.02 | 0.18 | 0.14 | 0.03 | n/a | n/a | n/a | n/a |
Quick Ratio | 4.50 | 4.52 | 6.42 | 8.69 | 6.10 | 8.49 | 15.29 | 13.90 | 17.98 |
Current Ratio | 4.50 | 4.52 | 5.53 | 4.10 | 6.04 | 8.49 | 15.29 | 13.90 | 17.98 |
Asset Turnover | 0.22 | 0.11 | 0.08 | 0.24 | 0.10 | 0.07 | 0.03 | 0.01 | n/a |
Interest Coverage | -82.5 | -170 | -140 | 208.65 | n/a | n/a | -11.15 | n/a | n/a |
Return on Equity (ROE) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Assets (ROA) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Capital (ROIC) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100.00% | -190.6% | 87.50% | 98.16% | -105.12% | -4.23% | -4.94% | -0.85% | n/a |
Net Profit Margin | -109.69% | -262.39% | -238.39% | 13.84% | -150.52% | -5.06% | -5.94% | -37.57% | n/a |
Pretax Profit Margin | -109.69% | -257.26% | -237.5% | 14.27% | -158.49% | -5.65% | -5.94% | -37.57% | n/a |
Operating Profit Margin | -127.91% | -290.6% | -250% | 14.17% | -160.27% | -5.91% | -6.57% | -37.82% | n/a |
FCF Margin | -68.22% | -282.05% | 380.36% | -73.72% | 139.47% | n/a | n/a | n/a | n/a |
EBITDA Margin | -104.26% | -241.88% | -223.21% | 16.18% | -152.83% | -5.41% | -6.13% | -35.97% | n/a |